cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.6541181.v1
title: Supplementary Material for: Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype

description: <b><i>Background:</i></b> Pregnancy-associated breast cancer (PABC) is rare and is generally defined as breast cancer diagnosed during pregnancy or within 1 year of delivery. The average ages of marriage and childbearing are increasing, and PABC is expected to also increase. This study is intended to increase understanding of the characteristics of PABC. <b><i>Methods:</i></b> A database of 2,810 patients with breast cancer diagnosed when they were less than 40 years of age was reviewed. The clinicopathological factors and survival of PABC (40 patients) were compared to those of patients with young breast cancer (YBC, non-pregnant or over 12 months after delivery; 2,770 patients). <b><i>Results:</i></b> PABC had significantly lower estrogen receptor (ER) and progesterone receptor (PR) expression (ER-positive 50.0%, PR-positive 45.0%) and higher HER2 overexpression (38.5%) than YBC. The most common subtype of PABC was triple-negative breast cancer (TNBC; 35.9%), and luminal A subtype represented only 7.7% of cases. In univariate analysis, PABC had significantly worse disease-free survival (DFS) and breast cancer-specific survival (BCSS) compared to YBC. In multivariate analysis, PABC was associated with worse BCSS (HR 4.0, 95% CI 1.2–12.9, <i>p</i> = 0.019) and survival, but there was no difference in DFS between PABC and YBC. In subgroup analysis by subtype, luminal B subtype of PABC showed worse DFS (HR 3.5; 95% CI 1.1–11.2, <i>p</i> = 0.039) and BCSS (HR 10.2, 95% CI 1.2–87.1, <i>p</i> = 0.035), especially with high Ki67. However, no differences were demonstrated in other subtypes. <b><i>Conclusion:</i></b> In this study, PABC showed lower expression of ER/PR, higher overexpression of HER2, fewer luminal A subtype, and more TNBC subtype compared to YBC. PABC had worse BCSS, especially luminal B subtype, compared to YBC.
DOI: 10.6084/m9.figshare.6541166
title: Delivering group speech maintenance therapy via telerehabilitation to people with Parkinson’s disease: A pilot study

description: <i>Purpose</i>: This study aimed to determine the feasibility of delivering a group speech maintenance programme (eLoud and Proud) to people with Parkinson’s disease via telerehabilitation. <i>Method</i>: Treatment was delivered to eight participants who had previously received LSVT LOUD®. The programme focussed on using a “loud” voice within conversational and cognitively loaded tasks, and was delivered in two 90-minute sessions per week for four weeks. Data pertaining to sound pressure level (SPL) (for sustained phonation, reading and monologue tasks), maximum frequency range, maximum phonation duration and impact of dysarthria on quality of life were collected at three time points: (1) pre-treatment (PRE); (2) immediately post-treatment (POST); and (3) three months post-treatment (FU). Participant satisfaction with telerehabilitation was also obtained at POST. <i>Result</i>: Significant improvements were identified for all SPL measures PRE-POST and maintained for sustained phonation and reading tasks at FU. No significant differences were identified for the remaining outcome measures. Participants were overall highly satisfied with telerehabilitation and considered it to be an acceptable alternative to traditional service delivery. <i>Conclusion</i>: This study demonstrated the feasibility of delivering group speech maintenance therapy via telerehabilitation, and the potential for eLoud and Proud to improve and maintain vocal loudness in people with PD.
DOI: 10.6084/m9.figshare.6541166.v1
title: Delivering group speech maintenance therapy via telerehabilitation to people with Parkinson’s disease: A pilot study

description: <i>Purpose</i>: This study aimed to determine the feasibility of delivering a group speech maintenance programme (eLoud and Proud) to people with Parkinson’s disease via telerehabilitation. <i>Method</i>: Treatment was delivered to eight participants who had previously received LSVT LOUD®. The programme focussed on using a “loud” voice within conversational and cognitively loaded tasks, and was delivered in two 90-minute sessions per week for four weeks. Data pertaining to sound pressure level (SPL) (for sustained phonation, reading and monologue tasks), maximum frequency range, maximum phonation duration and impact of dysarthria on quality of life were collected at three time points: (1) pre-treatment (PRE); (2) immediately post-treatment (POST); and (3) three months post-treatment (FU). Participant satisfaction with telerehabilitation was also obtained at POST. <i>Result</i>: Significant improvements were identified for all SPL measures PRE-POST and maintained for sustained phonation and reading tasks at FU. No significant differences were identified for the remaining outcome measures. Participants were overall highly satisfied with telerehabilitation and considered it to be an acceptable alternative to traditional service delivery. <i>Conclusion</i>: This study demonstrated the feasibility of delivering group speech maintenance therapy via telerehabilitation, and the potential for eLoud and Proud to improve and maintain vocal loudness in people with PD.
DOI: 10.6084/m9.figshare.6541124
title: Bruin Bike Storage Clean Data

description: Data collected from Winter to Spring 2018 of bike counts at the UCLA campus
DOI: 10.6084/m9.figshare.6541124.v1
title: Bruin Bike Storage Clean Data

description: Data collected from Winter to Spring 2018 of bike counts at the UCLA campus
DOI: 10.6084/m9.figshare.6540917
title: A density based empirical likelihood approach for testing bivariate normality

description: Sample entropy based tests, methods of sieves and Grenander estimation type procedures are known to be very efficient tools for assessing normality of underlying data distributions, in one-dimensional nonparametric settings. Recently, it has been shown that the density based empirical likelihood (EL) concept extends and standardizes these methods, presenting a powerful approach for approximating optimal parametric likelihood ratio test statistics, in a distribution-free manner. In this paper, we discuss difficulties related to constructing density based EL ratio techniques for testing bivariate normality and propose a solution regarding this problem. Toward this end, a novel bivariate sample entropy expression is derived and shown to satisfy the known concept related to bivariate histogram density estimations. Monte Carlo results show that the new density based EL ratio tests for bivariate normality behave very well for finite sample sizes. To exemplify the excellent applicability of the proposed approach, we demonstrate a real data example.
DOI: 10.6084/m9.figshare.6540917.v1
title: A density based empirical likelihood approach for testing bivariate normality

description: Sample entropy based tests, methods of sieves and Grenander estimation type procedures are known to be very efficient tools for assessing normality of underlying data distributions, in one-dimensional nonparametric settings. Recently, it has been shown that the density based empirical likelihood (EL) concept extends and standardizes these methods, presenting a powerful approach for approximating optimal parametric likelihood ratio test statistics, in a distribution-free manner. In this paper, we discuss difficulties related to constructing density based EL ratio techniques for testing bivariate normality and propose a solution regarding this problem. Toward this end, a novel bivariate sample entropy expression is derived and shown to satisfy the known concept related to bivariate histogram density estimations. Monte Carlo results show that the new density based EL ratio tests for bivariate normality behave very well for finite sample sizes. To exemplify the excellent applicability of the proposed approach, we demonstrate a real data example.
DOI: 10.6084/m9.figshare.6540779
title: Additional file 9: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, nacre acid-soluble, protocol B. See legend to Additional file 6. (XLSX 174Â kb)
DOI: 10.6084/m9.figshare.6540779.v1
title: Additional file 9: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, nacre acid-soluble, protocol B. See legend to Additional file 6. (XLSX 174Â kb)
DOI: 10.6084/m9.figshare.6540776
title: Additional file 8: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, nacre acid-insoluble, protocol B. See legend to Additional file 6. (XLSX 141Â kb)
DOI: 10.6084/m9.figshare.6540776.v1
title: Additional file 8: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, nacre acid-insoluble, protocol B. See legend to Additional file 6. (XLSX 141Â kb)
DOI: 10.6084/m9.figshare.6540773
title: Additional file 7: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, nacre acid-soluble, protocol A. See legend to Additional file 6. (XLSX 167Â kb)
DOI: 10.6084/m9.figshare.6540773.v1
title: Additional file 7: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, nacre acid-soluble, protocol A. See legend to Additional file 6. (XLSX 167Â kb)
DOI: 10.6084/m9.figshare.6540770
title: Additional file 6. of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, nacre acid-insoluble, protocol A. Slightly modified MaxQuant output table in xlsx format showing identified protein groups/proteins including those not finally accepted for various reasons. The table contains all accession numbers and various parameters such as iBAQ intensity, peptide count, sequence coverage, protein score and molecular weight. Contaminant and reversed sequence hits were removed. Identified vertebrate contaminating proteins were removed. (XLSX 103Â kb)
DOI: 10.6084/m9.figshare.6540770.v1
title: Additional file 6. of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, nacre acid-insoluble, protocol A. Slightly modified MaxQuant output table in xlsx format showing identified protein groups/proteins including those not finally accepted for various reasons. The table contains all accession numbers and various parameters such as iBAQ intensity, peptide count, sequence coverage, protein score and molecular weight. Contaminant and reversed sequence hits were removed. Identified vertebrate contaminating proteins were removed. (XLSX 103Â kb)
DOI: 10.6084/m9.figshare.6540743
title: Additional file 28: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Sequences of proteins used in proteome comparison. Conceptually derived protein sequences of 80 H. laevigata shell-forming proteins used in the generation of the Circoletto figure (Fig. 6). These sequences represent the 77 most abundant sequences from the shell described in Table 1 (77 proteins), and the minor proteins UP6 and UP7 (reported by Marie et al. [21]) which are encoded by three contigs. (TXT 32Â kb)
DOI: 10.6084/m9.figshare.6540743.v1
title: Additional file 28: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Sequences of proteins used in proteome comparison. Conceptually derived protein sequences of 80 H. laevigata shell-forming proteins used in the generation of the Circoletto figure (Fig. 6). These sequences represent the 77 most abundant sequences from the shell described in Table 1 (77 proteins), and the minor proteins UP6 and UP7 (reported by Marie et al. [21]) which are encoded by three contigs. (TXT 32Â kb)
DOI: 10.6084/m9.figshare.6540728
title: Additional file 26: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, prismatic layer acid-soluble, protocol B. See legend to Additional file 17. (XLSX 116Â kb)
DOI: 10.6084/m9.figshare.6540728.v1
title: Additional file 26: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, prismatic layer acid-soluble, protocol B. See legend to Additional file 17. (XLSX 116Â kb)
DOI: 10.6084/m9.figshare.6540719
title: Additional file 25: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, prismatic layer acid-insoluble, protocol B. See legend to Additional file 17. (XLSX 134Â kb)
DOI: 10.6084/m9.figshare.6540719.v1
title: Additional file 25: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, prismatic layer acid-insoluble, protocol B. See legend to Additional file 17. (XLSX 134Â kb)
DOI: 10.6084/m9.figshare.6540710
title: Additional file 1: of Assessing the predictors for training in management amongst hospital managers and chief executive officers: a cross-sectional study of hospitals in Abuja, Nigeria

description: Data collection on predictors for managerial trainings. (XLSX 29 kb)
DOI: 10.6084/m9.figshare.6540710.v1
title: Additional file 1: of Assessing the predictors for training in management amongst hospital managers and chief executive officers: a cross-sectional study of hospitals in Abuja, Nigeria

description: Data collection on predictors for managerial trainings. (XLSX 29 kb)
DOI: 10.6084/m9.figshare.6540707
title: Additional file 24: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, prismatic layer acid-soluble, protocol A. See legend to Additional file 17. (XLSX 884Â kb)
DOI: 10.6084/m9.figshare.6540707.v1
title: Additional file 24: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, prismatic layer acid-soluble, protocol A. See legend to Additional file 17. (XLSX 884Â kb)
DOI: 10.6084/m9.figshare.6540698
title: Additional file 23: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, prismatic layer acid-insoluble, protocol A. See legend to Additional file 17. (XLSX 902Â kb)
DOI: 10.6084/m9.figshare.6540698.v1
title: Additional file 23: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, prismatic layer acid-insoluble, protocol A. See legend to Additional file 17. (XLSX 902Â kb)
DOI: 10.6084/m9.figshare.6540689
title: Additional file 22: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, nacre acid-soluble, protocol C. See legend to Additional file 17. (XLSX 339Â kb)
DOI: 10.6084/m9.figshare.6540686
title: Additional file 2: of Health providers pass knowledge and abilities acquired by training in obstetric emergencies to their peers: the average treatment on the treated effect of PRONTO on delivery attendance in Mexico

description: Provider-level dataset. This dataset includes all relevant anonymized information of the study participantsâ as well as the birth observation variables during baseline and follow ups. (XLS 169 kb)
DOI: 10.6084/m9.figshare.6540689.v1
title: Additional file 22: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, nacre acid-soluble, protocol C. See legend to Additional file 17. (XLSX 339Â kb)
DOI: 10.6084/m9.figshare.6540686.v1
title: Additional file 2: of Health providers pass knowledge and abilities acquired by training in obstetric emergencies to their peers: the average treatment on the treated effect of PRONTO on delivery attendance in Mexico

description: Provider-level dataset. This dataset includes all relevant anonymized information of the study participantsâ as well as the birth observation variables during baseline and follow ups. (XLS 169 kb)
DOI: 10.6084/m9.figshare.6540677
title: Additional file 21: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, nacre acid-insoluble, protocol C. See legend to Additional file 17. (XLSX 555Â kb)
DOI: 10.6084/m9.figshare.6540677.v1
title: Additional file 21: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, nacre acid-insoluble, protocol C. See legend to Additional file 17. (XLSX 555Â kb)
DOI: 10.6084/m9.figshare.6540665
title: Additional file 20: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, nacre acid-soluble, protocol B. See legend to Additional file 17. (XLSX 587Â kb)
DOI: 10.6084/m9.figshare.6540665.v1
title: Additional file 20: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, nacre acid-soluble, protocol B. See legend to Additional file 17. (XLSX 587Â kb)
DOI: 10.6084/m9.figshare.6540635
title: Additional file 19: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, nacre acid-insoluble, protocol B. See legend to Additional file 17. (XLSX 547Â kb)
DOI: 10.6084/m9.figshare.6540635.v1
title: Additional file 19: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, nacre acid-insoluble, protocol B. See legend to Additional file 17. (XLSX 547Â kb)
DOI: 10.6084/m9.figshare.6540614
title: Additional file 18: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, nacre acid-soluble, protocol A. See legend to Additional file 17. (XLSX 432Â kb)
DOI: 10.6084/m9.figshare.6540614.v1
title: Additional file 18: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, nacre acid-soluble, protocol A. See legend to Additional file 17. (XLSX 432Â kb)
DOI: 10.6084/m9.figshare.6540599
title: Additional file 17: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, nacre acid-insoluble, protocol A. Slightly modified MaxQuant output table in xlsx format showing peptides to corresponding ProteinGroups files. The table contains the peptide sequences and various parameters such as peptide length, peptide mass, number of missed cleavages, charges, posterior error probabilities (PEP), peptide scores and peak intensities. Contaminant and reversed sequence hits were removed. (XLSX 287Â kb)
DOI: 10.6084/m9.figshare.6540599.v1
title: Additional file 17: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Peptides, nacre acid-insoluble, protocol A. Slightly modified MaxQuant output table in xlsx format showing peptides to corresponding ProteinGroups files. The table contains the peptide sequences and various parameters such as peptide length, peptide mass, number of missed cleavages, charges, posterior error probabilities (PEP), peptide scores and peak intensities. Contaminant and reversed sequence hits were removed. (XLSX 287Â kb)
DOI: 10.6084/m9.figshare.6540596
title: Additional file 4: of A bacterial route for folic acid supplementation

description: Table S3. Data corresponding to Fig. 5 in the main text. (XLSX 10Â kb)
DOI: 10.6084/m9.figshare.6540596.v1
title: Additional file 4: of A bacterial route for folic acid supplementation

description: Table S3. Data corresponding to Fig. 5 in the main text. (XLSX 10Â kb)
DOI: 10.6084/m9.figshare.6540584
title: Additional file 3: of A bacterial route for folic acid supplementation

description: Table S2. Data corresponding to Fig. 4 in the main text. (XLSX 50Â kb)
DOI: 10.6084/m9.figshare.6540584.v1
title: Additional file 3: of A bacterial route for folic acid supplementation

description: Table S2. Data corresponding to Fig. 4 in the main text. (XLSX 50Â kb)
DOI: 10.6084/m9.figshare.6540581
title: Additional file 16: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Distribution of nacre and prismatic layer proteins showing a summary of the distribution of the peptides of each identified protein among gel slices (fraction 1 to fraction 12). Fraction 111 shows the number of peptides in in-solution (FASP)-digested samples. Nacre proteins are contained in lines 3 to 641, prismatic layer proteins in lines 646 to 1285. The peptide distribution was derived from MaxQuant output files obtained by analysis of combined nacre sample raw-files and combined prismatic layer raw-files. (XLSX 303Â kb)
DOI: 10.6084/m9.figshare.6540581.v1
title: Additional file 16: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: Distribution of nacre and prismatic layer proteins showing a summary of the distribution of the peptides of each identified protein among gel slices (fraction 1 to fraction 12). Fraction 111 shows the number of peptides in in-solution (FASP)-digested samples. Nacre proteins are contained in lines 3 to 641, prismatic layer proteins in lines 646 to 1285. The peptide distribution was derived from MaxQuant output files obtained by analysis of combined nacre sample raw-files and combined prismatic layer raw-files. (XLSX 303Â kb)
DOI: 10.6084/m9.figshare.6540566
title: Additional file 15: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, prismatic layer acid-soluble, protocol B. See legend to Additional file 6. (XLSX 53Â kb)
DOI: 10.6084/m9.figshare.6540566.v1
title: Additional file 15: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, prismatic layer acid-soluble, protocol B. See legend to Additional file 6. (XLSX 53Â kb)
DOI: 10.6084/m9.figshare.6540557
title: Additional file 14: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, prismatic layer acid-insoluble, protocol B. See legend to Additional file 6. (XLSX 271Â kb)
DOI: 10.6084/m9.figshare.6540557.v1
title: Additional file 14: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, prismatic layer acid-insoluble, protocol B. See legend to Additional file 6. (XLSX 271Â kb)
DOI: 10.6084/m9.figshare.6540551
title: Additional file 1: of A bacterial route for folic acid supplementation

description: Table S1. Full analysis of lifespan conditions including statistical analysis. (XLSX 46Â kb)
DOI: 10.6084/m9.figshare.6540551.v1
title: Additional file 1: of A bacterial route for folic acid supplementation

description: Table S1. Full analysis of lifespan conditions including statistical analysis. (XLSX 46Â kb)
DOI: 10.6084/m9.figshare.6540536
title: Additional file 13: of In-depth proteomic analyses of Haliotis laevigata (greenlip abalone) nacre and prismatic organic shell matrix

description: ProteinGroups, prismatic layer acid-soluble, protocol A. See legend to Additional file 6. (XLSX 58Â kb)